Professional Documents
Culture Documents
in a transport
-Fluoroquinolone
medium
38 PCR for MRSA Swab Negative 48 h. 250
Throat swab or Nasal
Swab
39 PCR for Pneumocystis 72 h. 650
in a transport medium Negative
jirovecii provided by our lab
or Sputum or BAL
(Bronchoalveolar lavage)
PCR for TB
Any biological fluid at
42 (Mycobacterium tuberculosis complex) Negative 48 h. 600
least (2000 µL)
Including Rifampicin Sensitivity Test
Vaginal swab or
cervical swab or
51 Human papillomavirus Negative 72 h. 750
urethral swab
(28 Genotypes)
in a transport medium
provided by our lab
Vaginal swab
52 Human papillomavirus in a transport 400
16 & 18
Negative 72 h.
medium provided
by our lab
4- Genetic Polymorphism
53 IL 28B (Interleukin 28B) EDTA Blood See Report 96 h.
(s12r979860) 500
54 PCR for Apolipoprotein E Gene
Types ( Associated With Alzheimer's EDTA Blood See Report 96 h.
disease & Cardiovascular diseases ) 450
5 - Genetic Mutations
55 PCR for α-globin gene 1300
mutation
EDTA Blood See Report 96 h.
56 PCR for β-globin gene 1200
mutation
EDTA Blood See Report 96 h.
PCR for (21-B hydroxylase)
Gene Mutation EDTA Blood See Report 96 h. 700
57
Causing Congenital Adrenal
Hyperplasia
PCR for CVD
(Cardiovascular disease)
Panel including:
- Factor V
- Prothrombin gene (Factor II)
58 - MTHFR EDTA Blood See Report 96 h. 1250
- Factor XIII
- Plasminogen activator inhibitor 1
- ACE - Human platelet antigen 1
- ß-Fibrinogen
- Apolipoprotein B
- Apolipoprotein E
PCR for chromosome Y 750
59 Microdeletio
EDTA Blood See Report 48 h.
1 - Specific Panels
95 Anti platelet Abs (Direct) EDTA Blood Negative 96 h. 220
96 CD4/CD8 EDTA Blood See Report 96 h. 240
97 CD16/CD56 (NK cells) EDTA Blood See Report 96 h. 240
98 CD55/CD59 (PNH) EDTA Blood See Report 96 h. 240
EDTA Blood or
99 Immunophenotyping Bone marrow aspirate See Report 96h 850
(Acute panel) on EDTA
103 MRD (Minimal residual disease) Bone marrow See Report 96h 600
B lineage ALL aspirate on EDTA
104 Lymphocyte subsets cell
count CD3, CD4, CD8, EDTA Blood See Report 96h 600
(CD16/CD56), (CD19/CD20)
2 - Individual CDs
105 CD1a EDTA Blood See Report 96 h. 120
106 CD2 EDTA Blood See Report 96 h. 120
107 CD3 EDTA Blood See Report 96 h. 120
108 cyt.CD3 EDTA Blood See Report 96 h. 150
109 CD4 EDTA Blood See Report 96 h. 150
110 CD5 EDTA Blood See Report 96 h. 120
111 CD7 EDTA Blood See Report 96 h. 120
112 CD8 EDTA Blood See Report 96 h. 150
113 CD10 EDTA Blood See Report 96 h. 120
114 CD11b EDTA Blood See Report 96 h. 120
115 CD11c EDTA Blood See Report 96 h. 120
116 CD13 EDTA Blood See Report 96 h. 120
117 CD14 EDTA Blood See Report 96 h. 120
118 CD15 EDTA Blood See Report 96 h. 120
119 CD16 EDTA Blood See Report 96 h. 120
120 CD18 EDTA Blood See Report 96 h. 120
121 CD19 EDTA Blood See Report 96 h. 120
122 CD20 EDTA Blood See Report 96 h. 120
123 CD22 EDTA Blood See Report 96 h. 120
124 CD23 EDTA Blood See Report 96 h. 120
125 CD25 EDTA Blood See Report 96 h. 120
126 CD30 EDTA Blood See Report 96 h. 120
127 CD33 EDTA Blood See Report 96 h. 120
128 CD34 EDTA Blood See Report 96 h. 120
129 CD37 EDTA Blood See Report 96 h. 120
130 CD38 EDTA Blood See Report 96 h. 150
131 CD41a EDTA Blood See Report 96 h. 120
132 CD45 EDTA Blood See Report 96 h. 120
133 CD55 EDTA Blood See Report 96 h. 120
134 CD56 EDTA Blood See Report 96 h. 120
135 CD58 EDTA Blood See Report 96 h. 120
136 CD59 EDTA Blood See Report 96 h. 120
137 CD61 EDTA Blood See Report 96 h. 120
138 CD64 EDTA Blood See Report 96 h. 120
139 CD79a EDTA Blood See Report 96 h. 150
140 CD79b EDTA Blood See Report 96 h. 120
141 CD103 EDTA Blood See Report 96 h. 120
142 CD117 EDTA Blood See Report 96 h. 120
143 CD138 EDTA Blood See Report 96 h. 120
144 CD200 EDTA Blood See Report 96 h. 120
145 Cyclin D1 EDTA Blood See Report 96 h. 150
146 cyt.µ EDTA Blood See Report 96 h. 150
147 FMC-7 EDTA Blood See Report 96 h. 120
148 Glycophorin A EDTA Blood See Report 96 h. 120
149 Kappa EDTA Blood See Report 96 h. 120
150 cyt. Kappa EDTA Blood See Report 96 h. 150
151 Lambda EDTA Blood See Report 96 h. 120
152 cyt. Lambda EDTA Blood See Report 96 h. 150
153 MPO EDTA Blood See Report 96 h. 150
154 TCR γδ EDTA Blood See Report 96 h. 150
155 TdT EDTA Blood See Report 96 h. 150
156 ZAP-70 EDTA Blood See Report 96 h. 300
TESTS OF ELECTROPHORESIS
\
TUMOR MARKERS
236 PSA – Ratio (F.PSA/T.PSA ) Serum More than : 0.25 2 h. ---- ---
441 Galactomannan Ag For Serum Negative : Less than 0.5 24 h. Index 800
Aspergillus
442 Mannan Ag For Candida Serum Negative : < 1.4 24 h. U/mL 800
Equivocal : 1.4 - 2.6
Positive : > 2.6
THERAPEUTIC DRUGS
NO Test Name Specimen Reference Range Duration UNIT Price
443 Digoxin (Lanoxine) Serum Therapeutic level ( 0.5–2.0 ) 4 h. ng/ml 50
444 Carbamazepine ( Tegretol) Serum Therapeutic level ( 4 – 12 ) 4 h. µg/ml 40
445 Valporic acid (Depakene) Serum Therapeutic level (50 – 100) 4 h. µg/ml 65
446 Phenytoin (Epanutin) Serum Therapeutic level ( 10 – 20 ) 4 h. µg/ml 40
447 Cyclosporine (Sandimmune) EDTA Blood Therapeutic level (100– 400) 4 h. ng/ml 120
448 Lithium Serum Therapeutic level (0.5 – 1.5 ) 4 h. mmol/L 20
449 Sirolimus (Rapamune) EDTA Blood Therapeutic level ( 5 – 15 ) 5 Days ng/ml 300
450 Tacrolimus (FK 506 or Prograf) EDTA Blood Therapeutic level ( 5 – 20 ) 72 h. ng/ml 275
451 Methotrexate Serum Risk of toxicity is above 5 after 72 h. µmol/l 500
24h. of the dose
452 Everolimus (Certican) EDTA Blood Therapeutic level ( 3 – 8 ) 5 Days ng/ml 750
453 Theophylline Serum Therapeutic level ( 10 – 20 ) 24 h. µg/ml 150
454 Lamotrigine(Lamotrine, Lamictal) Serum Therapeutic level ( 3 – 15 ) 48 h. µg/ml 400
455 Oxcarbazepine Serum Therapeutic level: 48 h. µg/ml 600
(Trileptal, Oxaleptal) Adult : 3 – 35 [
Children : 15 – 55
456 Levetiracetam Serum Therapeutic level ( 6 – 46 ) 48 h. µg/ml 700
(Keppra, Tiratam, Levepex)
457 Adalimumab (Humira®) Serum Acceptable trough level: More than 1 72 h. µg/mL 1000
458 Anti-Adalimumab Ab Serum Less than 2.5 72 h. ng/mL 1000
459 Infliximab (Remicade®) Serum Acceptable trough level: More than 0.5 72 h. µg/mL 1000
460 Anti-Infliximab Serum Less than: 10 72 h. U/ml 1000
461 Phenobarbital Serum Therapeutic level : 15 - 40 48 h. µg/mL 450
DRUGS OF ABUSE
Urine or Undetectable
462 Alcohol 6 h. mg/dl 25
Serum
463 Amphetamines Undetectable 6 h. ng/ml
Urine 25
CDT (Carbohydrate-Deficient
464 Transferrin) Biomarker of Serum 28.1 - 76 --- mg/L 250
alcohol abuse
465 Barbiturates Urine Undetectable 6 h. ng/ml 25
466 Benzodiazepines Urine Undetectable 6 h. ng/ml 25
467 Cannabinoids Urine Undetectable 6 h. ng/ml 25
468 Cocaine Urine Undetectable 6 h. ng/ml 25
469 Flakka Synthetic street drug Urine Undetectable 24 h. 150
470 Strox, Voodoo Synthetic Urine Undetectable 24 h. 150
cannabinoids
471 Nicotine in Blood
(Quantitative) Serum Negative : Less than 25 24 h. ng/mL 90
(tobacco - smoking)
472 Opiate (Heroin-morphine ) Urine Undetectable 6 h. ng/ml 25
473 Tramadol Urine Undetectable 6 h. ng/ml 50
60 - 150
504 Protein S Citrated Plasma SPECIAL REFERENCE RANGE 4 h. % 120
0D-6M 12 - 60
505 Free Protein S Citrated Plasma 50 - 130 72 h. % 100
Fresh Urine Negative
506 Phenyl Ketonuria ( PKU ) 48 h. 40
sample
507 D- Dimer ( Quntitative ) Citrated Plasma Less than 250 2 h. ng/ml 100
508 B2- Microglobulin Serum 0.7 - 2.7 24 h. mg/l 40
509 B2- Microglobulin in urine Urine Up to : 0.2 24 h. mg/l 40
80 - 120
510 Anti thrombin III Citrated Plasma SPECIAL REFERENCE RANGE 2 h. % 60
Newborn 32 – 48
511 Alpha-1-antitrypsin Serum 90 - 200 24 h. mg/dl 40
512 Alpha-1-antitrypsin in stool Stool Less than 400 48 h. mg/g 250
513 Thrombin time Citrated Plasma Up to : 21 24 h. Sec 40
180 - 350
514 Fibrinogen level SPECIAL REFERENCE RANGE 25
Citrated Plasma 4 h. mg/dl
Pregnant (1st trimester) : 244 - 510
Pregnant (2st trimester) : 291 - 538
Pregnant (3st trimester) : 301 - 696
515 Cold agglutinins Serum Negative 5 Days 30
M : 15 - 40
F : 16 - 50
SPECIAL REFERENCE RANGE
516 Ceruloplasmin Serum New born – 4 M 15 - 56 24 h. mg/dl 40
5–6 M 26 – 83
7 – 36 M 31 – 90
4 – 12 M 25 – 45
197 - 771
SPECIAL REFERENCE RANGE.
0-1Y: M : 216 - 891 F: 168 -1117
517 Vitamin B12 Serum 2-3Y: M : 195 - 897 F: 307 - 892 4 h. pg/ml 80
4-6Y: M : 181 - 795 F: 231 - 038
7-9Y: M : 200 - 863 F: 182 - 866
10 - 12 Y: M : 135 - 803 F: 145 - 752
13 - 18 Y: M : 158 - 638 F: 134 - 605
545 FDP (Fibrinogen degradation Serum Less than 200 --- Ng/ml
products) 50
546 Homocysteine in urine Urine UP to : 5 4 h. µmol/L 120
Male : 4.92 - 42.7
547 Vitamin D Serum Female : 6.23 - 49.9 2 h. ng/ml 150
(25-OH vitamin D total ) Perferred level : < 30
Toxix level : < 100
548 1,25 OH ـــVitamin D Serum 17 - 53 7 day pg/ml 1100
Serum
549 1 (EPO) (Between 7:30 am 4.3 - 29 48 h. mU/ml 300
& 12:00 am)
70 - 120
550 Factor II Citrated Plasma SPECIAL REFERENCE RANGE 4 h. % 100
0 D - 6 M 10 - 100
70 - 140
551 Factor V Citrated Plasma SPECIAL REFERENCE RANGE 4 h. % 100
0D-6M 10 - 100
70 - 120
552 Factor VII Citrated Plasma SPECIAL REFERENCE RANGE 4 h. % 100
0D-6M 10 - 100
553 Factor VIII Citrated Plasma 70 - 150 4 h. % 100
70 - 120 100
554 Factor IX Citrated Plasma SPECIAL REFERENCE RANGE
4 h. %
0D-6M 10 - 100
70 - 120 120
555 Factor X Citrated Plasma 4 h. %
SPECIAL REFERENCE RANGE
0D-6M 10 - 100
70 - 120 100
556 Factor XI Citrated Plasma SPECIAL REFERENCE RANGE
4 h. %
0D-6M 10 – 100
70 - 150 100
557 Factor XII Citrated Plasma SPECIAL REFERENCE RANGE
4 h. %
0D-6M 10 - 100
70 - 140
558 Factor XIII Citrated Plasma SPECIAL REFERENCE RANGE 4 h. % 250
0D-6M 10 - 100
559 Factor VIII inhibitor Citrated Plasma Negative 72 h. 350
560 Heparin ( Anti factor X ) Citrated Plasma 0.3 - 0.7 72 h. U/ml 750
561 Haptoglobin Serum 30 - 200 24 h. mg/dl 80
562 Homocysteine Serum 5 - 15 2 h. µmol 120
563 Factor II Inhibitor Citrated Plasma Negative 72 h. 350
564 Factor V Inhibitor Citrated Plasma Negative 72 h. 350
565 Factor VII Inhibitor Citrated Plasma Negative 72 h. 350
Negative : ≤ 1.0
566 Factor IX Inhibitor Citrated Plasma Weakly Positive : 1.1 - 10 Strong 72 h. BU/ml 350
Positive : > 10
567 Factor X Inhibitor Citrated Plasma Negative 72 h. 350
Haematological Profile
653 Complete Blood Picture EDTA Blood Contact Lab 1 h. 35
654 CBC with Diff Report EDTA Blood See report 2 h. 50
Up to : 41
SPECIAL REFERENCE RANG
1 D: FullTerm : Up to 48.7
Premature : Up to 79.4
2 - 5 D : FullTerm : Up to 51.2
655 P.T.T Citrated Plasma Premature : Up to 74.1 1 h. Sec 7
6 - 30D : FullTerm : Up to 47.8
Premature : Up to 62.5
1 - 3 M : FullTerm : Up to 43.6
Premature : Up to 50.7
656 Mixing study PTT Citrated Plasma See report 24 h. 28
657 P.T Citrated Plasma Contact Lab 1 h. 7
658 Mixing study PT Citrated plasma See report 48 h. 28
659 Platelet count EDTA Blood Contact Lab 1 h. 20
660 Reticulocyte Count EDTA Blood Contact Lab 1 h. 25
661 Total leukocyt count EDTA Blood Contact Lab 1 h. 10
662 HB % EDTA Blood Contact Lab 1 h. g/dl 5
New Born : 36 - 184
663 Iron (Fe) Serum Less than 7 M : 37 - 145 1 h. 10
µg/dl
Adult Male : 59 - 158
Adult Female : 37 - 145
2 Bone Marrow direct
664 Bone Marrow Iron Stain films with particles See Report 96 h. 40
unstained
CBC report +
665 Bone Marrow Report peripheral blood EDTA
sample See Report 7 Days 200
Required : + 1 direct unstained
* Age * Medical history peripheral blood film
+ 2 Bone Marrow direct
films with particles
unstained
+ Bone marrow EDTA
sample
Up to : 1
SPECIAL REFERENCE RANGE
cord : FullTerm : < 2
690 Bilirubin Total Serum Premature : < 2 1 h. mg/dl 5
0 - 1 D FullTerm : Up to 6
Premature : Up to 8
1 - 2 D FullTerm : Up to 10
Premature : Up to 12
3 - 5 D FullTerm : Up to 12
Premature : Up to 14
Male : 11 - 60
Female : 7 - 40
691 Gamma – GT Serum SPECIAL REFERENCE RANGE 1 h. U/L 10
0 - 1 M : Up to 151
1 - 2 M : Up to 114
2 - 4 M : Up to 81
711 Uric acid /creatinine ratio 2nd morning urine 0.42 – 1.5 4 h. mg UA / mg 25
creat.
712 Total Protein in urine 24 h. urine Up to : 140 1 h. mg/day 15
10 - 50
713 Urea Serum SPECIAL REFERENCE RANGE 1 h. mg/dl 5
> 65 Y : Up to 71
D-3 Hydroxybutyrate